Atish P. Patel

Anesthesiology | Pain Medicine

4979 Old Street Road
Suite B
Trevose, PA 19053

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Bolstering the existing database supporting the non-cancer Threshold of Toxicological Concern values with toxicity data on fragrance-related materials.

Bolstering the existing database supporting the non-cancer Threshold of Toxicological Concern values with toxicity data on fragrance-related materials.

Journal: Regulatory toxicology and pharmacology : RTP

Published: March 25, 2020

Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.

Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.

Journal: Regulatory toxicology and pharmacology : RTP

Published: October 10, 2018

Oral 1-Generation Rat Reproduction Study of Isobornyl Acetate: An Evaluation Through Sexual Maturity in the F1 Generation.

Oral 1-Generation Rat Reproduction Study of Isobornyl Acetate: An Evaluation Through Sexual Maturity in the F1 Generation.

Journal: International journal of toxicology

Published: May 09, 2017

Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.

Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.

Journal: Pharmacological research

Published: January 18, 2017

The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.

The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.

Journal: Molecular cancer therapeutics

Published: August 01, 2016

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.

Journal: Oncotarget

Published: July 22, 2015

IKK inhibition increases bortezomib effectiveness in ovarian cancer.

IKK inhibition increases bortezomib effectiveness in ovarian cancer.

Journal: Oncotarget

Published: May 13, 2015

Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway.

Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway.

Journal: Biochimica et biophysica acta

Published: April 30, 2015

The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.

The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.

Journal: Oncotarget

Published: September 05, 2014

Silver nanoparticles: synthesis, properties, and therapeutic applications.

Silver nanoparticles: synthesis, properties, and therapeutic applications.

Journal: Drug discovery today

Published: September 03, 2014

Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.

Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.

Journal: Molecules (Basel, Switzerland)

Published: July 31, 2014

Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.

Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.

Journal: Oncotarget

Published: July 02, 2014

Showing 1-12 of 33

Last Updated: 09/26/2026